MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Laryngeal Dystonia, Dopa-Responsive Parkinsonism and Primary Progressive Aphasia with Alzheimer Disease Pathology

A. Eid, R. Perrin, J. Perlmutter, S. Norris (Saint Louis, USA)

Meeting: 2025 International Congress

Keywords: Parkinsonism, Primary progressive aphasia, Voice tremor

Category: Parkinsonism (Other)

Objective: To report a case of laryngeal dystonia (LD), parkinsonism and primary progressive aphasia (PPA) with Alzheimer disease (AD) pathology

Background: The presence of 3-4 neurological syndromes typically points to multiple pathologies explaining the heterogeneity. Here, we study one case that argues otherwise.

Method: Case report

Results: A 68-year-old left-handed woman presented with 4 years of tight, forced, tremulous voice with spontaneous voice breaks and mild bilateral hand action tremor. Diagnosed with adductor LD and essential tremor, she responded to thyroarytenoid botulinum toxin injections. At age 71, she developed progressive, dopa-responsive, asymmetric parkinsonism with rest tremor, rigidity, bradykinesia, postural instability (UPDRS 45) and mild word finding difficulty. At age 74, she developed progressive impairment in spontaneous speech, repetition, verbal fluency, abstraction and delayed recall (MOCA 20), consistent with logopenic PPA, that at age 78 involved all cognitive domains (MOCA 4). Post-mortem brain examination [1] following death at age 80 revealed advanced Alzheimer disease neuropathologic change (NIA-AA: High ADNC; A3, B3, C2 [Thal phase 5, Braak stage V]) consistent with the hippocampal-sparing variant [2], including frequent neurofibrillary tangles (NFTs) and severe neuronal loss in the locus coeruleus and moderate-to-frequent NFTs and regionally moderate neuronal loss in the substantia nigra, most pronounced laterally. Immunohistochemistry revealed no α-synuclein, TDP-43 or non-AD tau pathology (except for clinically inconsequential argyrophilic grain disease, Saito stage I).

Conclusion: Although there is a strong association between AD pathology and the logopenic PPA [3], additional clinical and pathological features in this patient are either atypical or exceedingly rare. For instance, only about 10% of AD patients without Lewy body pathology have parkinsonism [4]. Furthermore, the presence of parkinsonism with logopenic PPA is exceedingly rare. In fact, the presence of parkinsonism with PPA (typically agrammatic variant) points to a tauopathy e.g. progressive supranuclear palsy, not AD [5]. Additionally, there is no data suggesting that laryngeal dystonia is associated with either parkinsonism or AD. This case highlights the heterogenous nature of clinicopathologic relationships in neurodegenerative diseases that are increasingly recognized.

References: 1. Perrin RJ, Franklin EE, Bernhardt H, Burns A, Schwetye KE, Cairns NJ, Baxter M, Weiner MW, Morris JC; Alzheimer’s Disease Neuroimaging Initiative. The Alzheimer’s Disease Neuroimaging Initiative Neuropathology Core: An update. Alzheimers Dement. 2024 Nov;20(11):7859-7870. doi: 10.1002/alz.14253. Epub 2024 Oct 1.
PMID: 39351959; PMCID: PMC11567814

2. Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 2011 Sep;10(9):785-96. doi: 10.1016/S1474-4422(11)70156-9. Epub 2011 Jul 27. PMID: 21802369; PMCID: PMC3175379

3. Watanabe H, Duffy JR, Clark H, Machulda MM, Graff-Radford J, Thu Pham NT, Dickson DW, Lowe VJ, Whitwell JL, Josephs KA. Primary Progressive Aphasia Lacking Core Features of Nonfluent and Semantic Variants: Clinical, Neuroimaging, and Neuropathologic Features. Neurology. 2024 Nov 12;103(9):e209924. doi: 10.1212/WNL.0000000000209924. Epub 2024 Oct 8. PMID: 39656512; PMCID: PMC11474733.

4. Ono D, Sekiya H, Maier AR, Murray ME, Koga S, Dickson DW. Parkinsonism in Alzheimer’s disease without Lewy bodies in association with nigral neuron loss: A data-driven clinicopathologic study. Alzheimers Dement. 2025 Mar;21(3):e14628. doi: 10.1002/alz.14628. PMID: 40042515; PMCID: PMC11881629.

5. Graff-Radford J, Duffy JR, Strand EA, Josephs KA. Parkinsonian motor features distinguish the agrammatic from logopenic variant of primary progressive aphasia. Parkinsonism Relat Disord. 2012 Aug;18(7):890-2. doi: 10.1016/j.parkreldis.2012.04.011. Epub 2012 May 8. PMID: 22575236; PMCID: PMC3424382.

To cite this abstract in AMA style:

A. Eid, R. Perrin, J. Perlmutter, S. Norris. Laryngeal Dystonia, Dopa-Responsive Parkinsonism and Primary Progressive Aphasia with Alzheimer Disease Pathology [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/laryngeal-dystonia-dopa-responsive-parkinsonism-and-primary-progressive-aphasia-with-alzheimer-disease-pathology/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/laryngeal-dystonia-dopa-responsive-parkinsonism-and-primary-progressive-aphasia-with-alzheimer-disease-pathology/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley